MedTrace Logo

Microneedling-Assisted Delivery of Cetirizine Versus Latanoprost in Alopecia Areata

NCT07757867 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2026-08-11

No results posted yet for this study

Summary

This study planned to measure the effectiveness and safety of microneedling aided administration of cetirizine 1% versus latanoprost 0.01% in alopecia areata.

Conditions

Interventions

DRUG

Cetirizine (Zyrtec)

Patinets treated with microneedling-aided administration of topical cetirizine 1% solution

DRUG

Latanoprost

Patients treated with microneedling-aided administration of topical triamcinolone acetonide (TrA) (10mg/ml) as a positive control group

DRUG

Triamcinolone Acetonide

Patients treated with microneedling-aided administration of topical triamcinolone acetonide (TrA) (10mg/ml) as a positive control group

PROCEDURE

Microneedling only

Patientstreated with microneedling only as a negative control group

Sponsors & Collaborators

  • Tanta University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-10-01
Primary Completion
2024-10-01
Completion
2024-10-01

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07757867 on ClinicalTrials.gov